Showing results (91-100 of 491) with videos related to

Sort By:
Pageof 50
Journal of Thrombosis and Haemostasis : JTH|August 30, 2008
Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptorI Algaier, J A Jakubowski, F Asai, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1987
Effect of chronic low dose aspirin on platelet and vascular eicosanoid metabolism in nonhuman primates (Macaca fascicularis)J A Jakubowski, H L Bush, R Vaillancourt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet functionN L Dovlatova, J A Jakubowski, A Sugidachi, et al.
Bone Marrow Transplantation|July 31, 2001
Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host diseaseR J Brentjens, L Smith, L Reich, et al.
Cancers|October 14, 2022
Identification of Novel MET Exon 14 Skipping Variants in Non-Small Cell Lung Cancer Patients: A Prototype Workflow Involving in Silico Prediction and RT-PCRRiku Das, Maureen A Jakubowski, Jessica Spildener, et al.
British Journal of Haematology|August 1, 1985
Cumulative antiplatelet effect of low-dose enteric coated aspirinJ A Jakubowski, M J Stampfer, R Vaillancourt, et al.
Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemiaK S Kolbert, K A Hamacher, J G Jurcic, et al.
Blood|April 15, 1991
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combinationR M Lemoli, C Gasparetto, D A Scheinberg, et al.
Blood|October 25, 2001
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemiaJ G Jurcic, S D Nimer, D A Scheinberg, et al.
Pageof 50